NasdaqGS - Delayed Quote USD
Grifols, S.A. (GRFS)
7.35
+0.33
+(4.70%)
At close: May 2 at 4:00:01 PM EDT
7.35
0.00
(0.00%)
After hours: May 2 at 4:01:34 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 2 | 2 |
| Avg. Estimate | 0.16 | 0.2 | 0.98 | 1.35 |
| Low Estimate | 0.16 | 0.2 | 0.82 | 1.18 |
| High Estimate | 0.16 | 0.2 | 1.13 | 1.52 |
| Year Ago EPS | -- | 0.15 | 0.68 | 0.98 |
Revenue Estimate
| Currency in EUR | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 3 | 1 | 11 | 11 |
| Avg. Estimate | 1.73B | 1.91B | 7.7B | 8.24B |
| Low Estimate | 1.72B | 1.91B | 7.54B | 8.02B |
| High Estimate | 1.73B | 1.91B | 8.07B | 8.61B |
| Year Ago Sales | 1.63B | 1.82B | 7.21B | 7.7B |
| Sales Growth (year/est) | 6.19% | 5.29% | 6.70% | 7.06% |
Earnings History
| Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | 0.16 | 0.23 | 0.24 | 0.23 |
| EPS Actual | -- | 0.15 | -- | -- |
| Difference | -- | -0.07 | -- | -- |
| Surprise % | -- | -32.56% | -- | -- |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0.16 | 0.2 | 0.98 | 1.35 |
| 7 Days Ago | 0 | 0 | 0.82 | 1.33 |
| 30 Days Ago | 0 | 0 | 0.82 | 1.33 |
| 60 Days Ago | 0 | 0 | 1.05 | 1.47 |
| 90 Days Ago | 0 | 0 | 1.05 | 1.47 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | 1 |
| Up Last 30 Days | -- | -- | -- | 1 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| GRFS | -- | 34.15% | 42.45% | 38.17% |
| S&P 500 | 11.38% | 3.78% | 8.23% | 13.76% |
Upgrades & Downgrades
| Downgrade | Deutsche Bank: Hold to Sell | 3/12/2024 |
| Maintains | JP Morgan: Neutral to Neutral | 12/5/2023 |
| Downgrade | Deutsche Bank: Buy to Hold | 11/5/2021 |
| Upgrade | Credit Suisse: Neutral to Outperform | 3/23/2021 |
| Upgrade | HSBC: Hold to Buy | 3/11/2021 |
| Upgrade | Santander: Hold to Buy | 10/28/2019 |
Related Tickers
SNY Sanofi
55.44
+2.48%
BIIB Biogen Inc.
123.53
+2.15%
BAYRY Bayer Aktiengesellschaft
6.74
-0.15%
AZNCF AstraZeneca PLC
146.74
0.00%
NVS Novartis AG
114.29
+2.66%
RHHBY Roche Holding AG
41.08
-0.12%
GSK GSK plc
39.07
+0.83%
OGN Organon & Co.
9.59
+1.48%
BAYA.BE Bayer AG
6.00
+3.45%
AMGN.MX Amgen Inc.
5,510.00
0.00%